Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, June 20, 2016
[ Mon, Jun 20th 2016
] - WOPRAI
Fri, June 17, 2016
[ Fri, Jun 17th 2016
] - WOPRAI
[ Fri, Jun 17th 2016
] - WOPRAI
Thu, June 16, 2016
[ Thu, Jun 16th 2016
] - WOPRAI
[ Thu, Jun 16th 2016
] - WOPRAI
[ Thu, Jun 16th 2016
] - WOPRAI
[ Thu, Jun 16th 2016
] - WOPRAI
[ Thu, Jun 16th 2016
] - WOPRAI
[ Thu, Jun 16th 2016
] - WOPRAI
[ Thu, Jun 16th 2016
] - WOPRAI
[ Thu, Jun 16th 2016
] - WOPRAI
[ Thu, Jun 16th 2016
] - WOPRAI
[ Thu, Jun 16th 2016
] - WOPRAI
[ Thu, Jun 16th 2016
] - WOPRAI
[ Thu, Jun 16th 2016
] - WOPRAI
[ Thu, Jun 16th 2016
] - WOPRAI
[ Thu, Jun 16th 2016
] - WOPRAI
[ Thu, Jun 16th 2016
] - WOPRAI
Wed, June 15, 2016
[ Wed, Jun 15th 2016
] - WOPRAI
[ Wed, Jun 15th 2016
] - WOPRAI
[ Wed, Jun 15th 2016
] - WOPRAI
[ Wed, Jun 15th 2016
] - WOPRAI
[ Wed, Jun 15th 2016
] - WOPRAI
Andrew Fein Downgraded (UTHR) to Hold and Decreased Target to $95 on, Jun 15th, 2016
Andrew Fein of HC Wainwright & Co., Downgraded "United Therapeutics Corporation" (UTHR) to Hold and Decreased Target from $175 to $95 on, Jun 15th, 2016.
Andrew has made no other calls on UTHR in the last 4 months.
There are 3 other peers that have a rating on UTHR. Out of the 3 peers that are also analyzing UTHR, all agree with Andrew's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Jasper Hellweg of "Argus Research" Downgraded from Strong Buy to Hold on, Tuesday, May 24th, 2016
- Matthew Kaplan of "Ladenburg Thalmann" Downgraded from Strong Buy to Hold on, Friday, April 29th, 2016
- Geoff Meacham of "Barclays" Maintained at Hold with Decreased Target to $145 on, Friday, February 26th, 2016
